Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bio-Rad Laboratories, Inc. (BIO) vs Penumbra, Inc. (PEN)

Bio-Rad Laboratories, Inc. and Penumbra, Inc. are both Medical Devices companies. Penumbra, Inc. is the larger, with a market value of $12.6B against $10.4B — 1.2× the size. Bio-Rad Laboratories, Inc. trades at the lower P/E: 45.7× against 78.0×. Penumbra, Inc. grew revenue faster over the last twelve months: 17.6% against 1.37%. Penumbra, Inc. has the higher net margin (10.7% vs 8.59%) and the higher return on invested capital (13.1% vs 0.49%). Across the 22 metrics below, Penumbra, Inc. leads on 14 and Bio-Rad Laboratories, Inc. on 8.

Valuation

Metric BIO PEN Medical Devices median
P/E 45.74 77.97 22.18
P/S 3.94 8.34 2.70
P/B 1.42 8.20 2.46
Price to free cash flow 28.70 58.13 22.53
EV/EBITDA 184.10 58.25 11.78
EV/Sales 3.78 7.91 2.38
Earnings yield 2.19% 1.28% (8.22%)
Free cash flow yield 3.48% 1.72% (7.80%)

Profitability

Metric BIO PEN Medical Devices median
Gross margin 51.90% 67.84% 56.01%
Operating margin 2.05% 12.45% (15.03%)
Net margin 8.59% 10.67% (20.40%)
Free cash flow margin 13.64% 14.35% (7.24%)
Return on equity 3.11% 11.37% (15.32%)
Return on assets 2.17% 8.80% (19.72%)
Return on invested capital 0.49% 13.13% (10.33%)

Growth

Metric BIO PEN Medical Devices median
Revenue growth (TTM) 1.37% 17.55% 8.80%
EPS growth (last fiscal year) 142.61% 1,155.56% —
Revenue growth, 5-year CAGR 0.29% 20.16% 15.23%
Net income growth, 5-year CAGR (27.58%) 0.00% 0.00%

Health

Metric BIO PEN Medical Devices median
Debt to equity 0.17 0.01 0.07
Current ratio 3.14 5.75 2.50
Net debt to EBITDA (7.15) (2.54) 0.49

Dividend

Metric BIO PEN Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric BIO PEN Medical Devices median
Market cap 10.41b 12.59b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack